Table of Contents

1 Study Coverage

• 1.1 Ofloxacin Product Introduction
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Ofloxacin Market Size Growth Rate by Type
  • 1.4.2 Oral
  • 1.4.3 Intravenous Therapy (IV)
  • 1.4.4 Topical (Eye Drops & Ear Drops)
• 1.5 Market by Application
  • 1.5.1 Global Ofloxacin Market Size Growth Rate by Application
  • 1.5.2 Hospital Pharmacies
  • 1.5.3 Retail Pharmacies
  • 1.5.4 Online Pharmacies
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Ofloxacin Market Size
  • 2.1.1 Global Ofloxacin Revenue 2014-2025
  • 2.1.2 Global Ofloxacin Sales 2014-2025
• 2.2 Ofloxacin Growth Rate by Regions
  • 2.2.1 Global Ofloxacin Sales by Regions
  • 2.2.2 Global Ofloxacin Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Ofloxacin Sales by Manufacturers
  • 3.1.1 Ofloxacin Sales by Manufacturers
  • 3.1.2 Ofloxacin Sales Market Share by Manufacturers
• 3.2 Ofloxacin Revenue by Manufacturers
  • 3.2.1 Ofloxacin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Ofloxacin Revenue Share by Manufacturers (2014-2019)
• 3.3 Ofloxacin Price by Manufacturers
• 3.4 Ofloxacin Manufacturing Base Distribution, Product Types
  • 3.4.1 Ofloxacin Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Ofloxacin Product Type
  • 3.4.3 Date of International Manufacturers Enter into Ofloxacin Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

• 4.1 Global Ofloxacin Sales by Type
• 4.2 Global Ofloxacin Revenue by Type
• 4.3 Ofloxacin Price by Type

5 Breakdown Data by Application

• 5.1 Overview
• 5.2 Global Ofloxacin Breakdown Data by Application

6 North America

• 6.1 North America Ofloxacin by Country
  • 6.1.1 North America Ofloxacin Sales by Country
  • 6.1.2 North America Ofloxacin Revenue by Country
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Ofloxacin by Type
• 6.3 North America Ofloxacin by Application

7 Europe

• 7.1 Europe Ofloxacin by Country
  • 7.1.1 Europe Ofloxacin Sales by Country
  • 7.1.2 Europe Ofloxacin Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Ofloxacin by Type
• 7.3 Europe Ofloxacin by Application

8 Asia Pacific

• 8.1 Asia Pacific Ofloxacin by Country
  • 8.1.1 Asia Pacific Ofloxacin Sales by Country
  • 8.1.2 Asia Pacific Ofloxacin Revenue by Country
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Ofloxacin by Type
• 8.3 Asia Pacific Ofloxacin by Application

9 Central & South America

• 9.1 Central & South America Ofloxacin by Country
  • 9.1.1 Central & South America Ofloxacin Sales by Country
  • 9.1.2 Central & South America Ofloxacin Revenue by Country
  • 9.1.3 Brazil
  • 9.1.4 Argentina
• 9.2 Central & South America Ofloxacin by Type
• 9.3 Central & South America Ofloxacin by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Ofloxacin by Country
  • 10.1.1 Middle East and Africa Ofloxacin Sales by Country
  • 10.1.2 Middle East and Africa Ofloxacin Revenue by Country
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Ofloxacin by Type
• 10.3 Middle East and Africa Ofloxacin by Application

11 Company Profiles

• 11.1 Novartis
  • 11.1.1 Novartis Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Novartis Ofloxacin Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Novartis Ofloxacin Products Offered
  • 11.1.5 Novartis Recent Development
• 11.2 Teva
  • 11.2.1 Teva Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Teva Ofloxacin Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Teva Ofloxacin Products Offered
  • 11.2.5 Teva Recent Development
• 11.3 Allergan
  • 11.3.1 Allergan Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Allergan Ofloxacin Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Allergan Ofloxacin Products Offered
  • 11.3.5 Allergan Recent Development
• 11.4 Apotex
  • 11.4.1 Apotex Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Apotex Ofloxacin Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Apotex Ofloxacin Products Offered
  • 11.4.5 Apotex Recent Development
• 11.5 Janssen
  • 11.5.1 Janssen Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Janssen Ofloxacin Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Janssen Ofloxacin Products Offered
  • 11.5.5 Janssen Recent Development
• 11.6 Daiichi Sankyo
  • 11.6.1 Daiichi Sankyo Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Daiichi Sankyo Ofloxacin Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Daiichi Sankyo Ofloxacin Products Offered
  • 11.6.5 Daiichi Sankyo Recent Development
• 11.7 Cadila Pharmaceuticals
  • 11.7.1 Cadila Pharmaceuticals Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Cadila Pharmaceuticals Ofloxacin Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Cadila Pharmaceuticals Ofloxacin Products Offered
  • 11.7.5 Cadila Pharmaceuticals Recent Development
• 11.8 Bestochem
  • 11.8.1 Bestochem Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Bestochem Ofloxacin Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Bestochem Ofloxacin Products Offered
  • 11.8.5 Bestochem Recent Development
• 11.9 Almatica Pharma
  • 11.9.1 Almatica Pharma Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Almatica Pharma Ofloxacin Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Almatica Pharma Ofloxacin Products Offered
  • 11.9.5 Almatica Pharma Recent Development

12 Future Forecast

• 12.1 Ofloxacin Market Forecast by Regions
  • 12.1.1 Global Ofloxacin Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Ofloxacin Revenue Forecast by Regions 2019-2025
• 12.2 Ofloxacin Market Forecast by Type
  • 12.2.1 Global Ofloxacin Sales Forecast by Type 2019-2025
  • 12.2.2 Global Ofloxacin Revenue Forecast by Type 2019-2025
• 12.3 Ofloxacin Market Forecast by Application
• 12.4 North America Ofloxacin Forecast
• 12.5 Europe Ofloxacin Forecast
• 12.6 Asia Pacific Ofloxacin Forecast
• 12.7 Central & South America Ofloxacin Forecast
• 12.8 Middle East and Africa Ofloxacin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Ofloxacin Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Ofloxacin is a synthetic fluoroquinolone (fluoroquinolones) antibacterial agent useful for the treatment of a number of bacterial infections.
The global Ofloxacin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ofloxacin market based on company, product type, end user and key regions.

This report studies the global market size of Ofloxacin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ofloxacin in these regions.
This research report categorizes the global Ofloxacin market by top players/brands, region, type and end user. This report also studies the global Ofloxacin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Teva
Allergan
Apotex
Janssen
Daiichi Sankyo
Cadila Pharmaceuticals
Bestochem
Almatica Pharma

Ofloxacin market size by Type
Oral
Intravenous Therapy (IV)
Topical (Eye Drops & Ear Drops)
Ofloxacin market size by Applications
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Ofloxacin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Ofloxacin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ofloxacin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ofloxacin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ofloxacin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ofloxacin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.